Drug Database
Back to search

Switzerland· 69771002

Nilotinib Spirig HC 150 mg, Hartkapseln

A other antineoplastic agents product containing nilotinibum, registered in Switzerland by Spirig HealthCare AG and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 5 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC L01X

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedNilotinib Spirig HC 150 mg, Hartkapse…ATCL01XREGISTER NO.69771002PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about nilotinibumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nilotinibum is registered in 5 of 19 countries.

Countries holding a registration under ATC L01X (other antineoplastic agents), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 3 of them publish a price we can compare per daily dose
Search nilotinibum products by name

Nilotinibum · ATC L01X

5 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Ireland
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
nilotinibum
Manufacturer
Spirig HealthCare AG
Country
Switzerland (CH)
ATC code
L01X
ATC class
OTHER ANTINEOPLASTIC AGENTS
Swissmedic category
A
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680697710029
    Blist 112 Stk
    CHF 1036.95

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Nilotinibum in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nilotinibum products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Nilotinib Stada, Nilotinib Teva
  • Belgium · Nilotinb Eg, Nilotinib
  • Bulgaria · Нилотиниб Зентива, Нилотиниб Стада
  • Cyprus · Nilotinib Bioars, Nilotinib Olpha
  • Czechia · Nilotinib, Nilotinib Stada
  • Germany · Nilotinib Al, Nilotinib Al 150 Mg Hartkapseln Al
  • Denmark · Nilotinib "olpha", Nilotinib Stada
  • Estonia · Nilotinib Olpha, Nilotinib Stada
  • Spain · Nilotinib Cipla, Nilotinib Eugia
  • Finland · Nilotinib Stada, Nilotinib Zentiva
  • France · Nilotinib Arrow, Nilotinib Biogaran
  • United Kingdom (Northern Ireland) · Nilotinib Amarox, Nilotinib Teva Uk
  • Greece · Lobynia, Nilotinib Anabiosis
  • Croatia · Nilmat, Nilotinib Devatis
  • Hungary · Krufton, Nilotinib
  • Ireland · Nilotinib Clonmel
  • Iceland · Nilotinib, Nilotinib Accord
  • Italy · Nilotinib Cipla, Nilotinib Eg
  • Liechtenstein · Nilotinib Accord, Tasigna
  • Lithuania · Krufton, Nilotinib Olpha
  • Luxembourg · Nilotinib Eg, Nilotinib Eugia
  • Latvia · Krufton, Nilotinib Olpha
  • Malta · Nilotinib Hydrochloride Dihydrate Clonmel, Nilotinib Olpha
  • Netherlands · Nilotinib Cf, Nilotinib Cipla
  • Norway · Nilotinib Accord, Nilotinib Cipla
  • Poland · Nilotinib Stada, Nilotinib Viatris
  • Portugal · Nilotinib Eugia, Nilotinib Generis
  • Romania · Krufton, Nilotinib Cipla
  • Sweden · Nilotinib Cipla, Nilotinib Devatis
  • Slovenia · Nilmat, Nilotinib Stada
  • Slovakia · Krufton, Nilotinib

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fb54302c-9f7e-482c-93cc-5179385668e9
GET /v1/drugs/fb54302c-9f7e-482c-93cc-5179385668e9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "nilotinibum 150 mg",
  "valid_from": "2025-09-01",
  "limitations": "[{\"description\":\"Erstlinienbehandlung von erwachsenen Patienten mit Philadelphiachromosom-positiver chronischer myeloischer Leukämie (Ph+ CML) in der chronischen Phase.<br>\\n<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2025-09-01\"}]",
  "galenic_form": "Kaps 150 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2025-09-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about nilotinibum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console